[WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.](https://wbbsec.com/press-releases/wbb-securities-invites-you-to-attend-the-upcoming-demy-colton-virtual-salon-titled-seven-years-after-fda-approval-what-have-we-learned-about-cell-and-gene-therapies/)
[WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.](https://wbbsec.com/press-releases/wbb-securities-invites-you-to-attend-the-upcoming-demy-colton-virtual-salon-titled-seven-years-after-fda-approval-what-have-we-learned-about-cell-and-gene-therapies/)
In: Press Releases

For Immediate Release

 

May 27, 2025

 

Cranford, NJ – WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled:
“Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”. The Salon will be hosted by the WBB Research Institute and DemyColton at 11:00 a.m. EDT on Wednesday, May 28.

This virtual event will bring together leaders in the life sciences to discuss the current state of cell and gene therapy, the progress made since the FDA’s first approval, and the challenges that still lie ahead.

Salon hosts are:

Sara Jane Demy, DemyColton

Steve Brozak, DMH – WBB Securities and Richard Marfuggi, MD, DMH – WBB Research Institute

 

Panel participants include:

Malcolm Brenner: MD, PhD, Professor, Center for Cell & Gene Therapy and Founding Director, Center for Cell and Gene Therapy, Baylor College of Medicine

Helen Heslop: MD, Professor, Department of Medicine & Pediatrics, and Director, Center for Cell and Gene Therapy, Baylor College of Medicine

Manali Kamdar: MD, Associate Professor of Medicine and Clinical Director of Lymphoma Services, University of Colorado

Geoffrey Shouse, DO, PhD, Hematologist-Oncologist & Researcher, City of Hope

Juan Vera, MD, President & CEO, Marker Therapeutics

📅 Event Registration:
Click here to join

Join this forward-looking conversation at the intersection of science, policy, and patient impact.

About WBB Securities.

WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily on the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of FINRA, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.

 

www.wbbsec.com

 

 

 

About WBB Research Institute.

The WBB Research Institute is a newly formed, independent, non-ideological, public policy research center fostering and applying specialized knowledge to various health issues.

 

www.wbbri.com

 

 

 

About Demy-Colton.

Demy Colton is a leader in biotech and life science events; with over 20 years of experience connecting leaders of innovative biotech companies with key stakeholders, investors, and advisors, we create ideal environments to examine and address opportunities and challenges in today’s biotech industry.

 

www.demy-colton.com